Melanie A Ortleb, MD | |
16910 Frances St, Omaha, NE 68130-2368 | |
(402) 505-8777 | |
(402) 933-7767 |
Full Name | Melanie A Ortleb |
---|---|
Gender | Female |
Speciality | Dermatology |
Experience | 13 Years |
Location | 16910 Frances St, Omaha, Nebraska |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154611622 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 28493 (Nebraska) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
The Nebraska Medical Center | Omaha, NE | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mod Dermatology Pc | 9638430804 | 7 |
News Archive
Formatech continues its pledge to give back and make a difference in the biotechnology and pharmaceutical community with its Fillanthropy Program. Since the program's inception, Formatech has donated $308K in aseptic liquid fill and finish manufacturing services to companies developing new drug therapies.
Vanderbilt University researchers have relieved symptoms of Rett syndrome in a mouse model with a small molecule that works like the dimmer switch in an electrical circuit.
InNexus Biotechnology Inc., a biopharmaceutical company creating and developing innovative solutions for cancer, inflammation and other difficult-to-treat diseases, announces that it has, effective August 26, 2011, granted incentive stock options to purchase an aggregate of 1,068,683 common shares without par value in the capital of the Company to certain persons who are either a director, officer, employee or consultant of the Company.
A research group at the RIKEN Center for Computational Science (R-CCS) has found that glycans—sugar molecules—play an important role in the structural changes that take place when the virus which causes COVID-19 invades human cells.
› Verified 6 days ago
Entity Name | Mod Dermatology Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1982105425 PECOS PAC ID: 9638430804 Enrollment ID: O20180302002386 |
News Archive
Formatech continues its pledge to give back and make a difference in the biotechnology and pharmaceutical community with its Fillanthropy Program. Since the program's inception, Formatech has donated $308K in aseptic liquid fill and finish manufacturing services to companies developing new drug therapies.
Vanderbilt University researchers have relieved symptoms of Rett syndrome in a mouse model with a small molecule that works like the dimmer switch in an electrical circuit.
InNexus Biotechnology Inc., a biopharmaceutical company creating and developing innovative solutions for cancer, inflammation and other difficult-to-treat diseases, announces that it has, effective August 26, 2011, granted incentive stock options to purchase an aggregate of 1,068,683 common shares without par value in the capital of the Company to certain persons who are either a director, officer, employee or consultant of the Company.
A research group at the RIKEN Center for Computational Science (R-CCS) has found that glycans—sugar molecules—play an important role in the structural changes that take place when the virus which causes COVID-19 invades human cells.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Melanie A Ortleb, MD 16910 Frances St, Omaha, NE 68130-2398 Ph: (402) 505-8777 | Melanie A Ortleb, MD 16910 Frances St, Omaha, NE 68130-2368 Ph: (402) 505-8777 |
News Archive
Formatech continues its pledge to give back and make a difference in the biotechnology and pharmaceutical community with its Fillanthropy Program. Since the program's inception, Formatech has donated $308K in aseptic liquid fill and finish manufacturing services to companies developing new drug therapies.
Vanderbilt University researchers have relieved symptoms of Rett syndrome in a mouse model with a small molecule that works like the dimmer switch in an electrical circuit.
InNexus Biotechnology Inc., a biopharmaceutical company creating and developing innovative solutions for cancer, inflammation and other difficult-to-treat diseases, announces that it has, effective August 26, 2011, granted incentive stock options to purchase an aggregate of 1,068,683 common shares without par value in the capital of the Company to certain persons who are either a director, officer, employee or consultant of the Company.
A research group at the RIKEN Center for Computational Science (R-CCS) has found that glycans—sugar molecules—play an important role in the structural changes that take place when the virus which causes COVID-19 invades human cells.
› Verified 6 days ago
Dr. Ronald John Sulewski Jr., M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4014 Leavenworth St, Omaha, NE 68105 Phone: 402-552-7928 | |
Tomas Huerta, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 16120 W Dodge Rd, Omaha, NE 68118 Phone: 402-354-0670 Fax: 402-354-0675 | |
Mr. John R Luckasen, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 4242 Farnam St, Ste 360, Omaha, NE 68131 Phone: 402-552-2555 Fax: 402-552-2573 | |
David J Watts, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 909 N 96th St, Suite 201, Omaha, NE 68114 Phone: 402-330-4555 Fax: 402-934-0945 | |
Dr. Sara Elizabeth West, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 909 N 96th St, Suite 201, Omaha, NE 68114 Phone: 402-330-4555 Fax: 402-934-0945 | |
Dr. Scott M Debates, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 515 N 162nd Avennue, Ste. 302, Omaha, NE 68118 Phone: 402-354-0621 Fax: 402-354-0611 |